NEW YORK, Feb 14 - PerkinElmer, a stockholder in Genomic Solutions and holder of foreign distribution rights to some of Genomic Solutions' gene and protein analysis products, has sued Genomic Solutions and its directors in Delaware Chancery Court, seeking to block a "proposed transaction."

Under Genomic Solutions' terms of incorporation, PerkinElmer has a "call right" allowing it to call and redeem all shares of Genomic Solutions that PerkinElmer does not own.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.